1
|
Luo P, Huang JH, Lv JM, Wang GQ, Hu D, Gao H. Biosynthesis of fungal terpenoids. Nat Prod Rep 2024; 41:748-783. [PMID: 38265076 DOI: 10.1039/d3np00052d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2024]
Abstract
Covering: up to August 2023Terpenoids, which are widely distributed in animals, plants, and microorganisms, are a large group of natural products with diverse structures and various biological activities. They have made great contributions to human health as therapeutic agents, such as the anti-cancer drug paclitaxel and anti-malarial agent artemisinin. Accordingly, the biosynthesis of this important class of natural products has been extensively studied, which generally involves two major steps: hydrocarbon skeleton construction by terpenoid cyclases and skeleton modification by tailoring enzymes. Additionally, fungi (Ascomycota and Basidiomycota) serve as an important source for the discovery of terpenoids. With the rapid development of sequencing technology and bioinformatics approaches, genome mining has emerged as one of the most effective strategies to discover novel terpenoids from fungi. To date, numerous terpenoid cyclases, including typical class I and class II terpenoid cyclases as well as emerging UbiA-type terpenoid cyclases, have been identified, together with a variety of tailoring enzymes, including cytochrome P450 enzymes, flavin-dependent monooxygenases, and acyltransferases. In this review, our aim is to comprehensively present all fungal terpenoid cyclases identified up to August 2023, with a focus on newly discovered terpenoid cyclases, especially the emerging UbiA-type terpenoid cyclases, and their related tailoring enzymes from 2015 to August 2023.
Collapse
Affiliation(s)
- Pan Luo
- Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education of China, Jinan University, Guangzhou 510632, China.
| | - Jia-Hua Huang
- Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education of China, Jinan University, Guangzhou 510632, China.
| | - Jian-Ming Lv
- Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education of China, Jinan University, Guangzhou 510632, China.
| | - Gao-Qian Wang
- Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education of China, Jinan University, Guangzhou 510632, China.
| | - Dan Hu
- Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education of China, Jinan University, Guangzhou 510632, China.
| | - Hao Gao
- Institute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education of China, Jinan University, Guangzhou 510632, China.
| |
Collapse
|
2
|
Gu B, Goldfuss B, Dickschat JS. Two Sesterterpene Synthases from Lentzea atacamensis Demonstrate the Role of Conformational Variability in Terpene Biosynthesis. Angew Chem Int Ed Engl 2024; 63:e202401539. [PMID: 38372063 DOI: 10.1002/anie.202401539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Revised: 02/15/2024] [Accepted: 02/16/2024] [Indexed: 02/20/2024]
Abstract
Mining of two multiproduct sesterterpene synthases from Lentzea atacamensis resulted in the identification of the synthases for lentzeadiene (LaLDS) and atacamatriene (LaATS). The main product of LaLDS (lentzeadiene) is a new compound, while one of the side products (lentzeatetraene) is the enantiomer of brassitetraene B and the other side product (sestermobaraene F) is known from a surprisingly distantly related sesterterpene synthase. LaATS produces six new compounds, one of which is the enantiomer of the known sesterterpene Bm1. Notably, for both enzymes the products cannot all be explained from one and the same starting conformation of geranylfarnesyl diphosphate, demonstrating the requirement of conformational flexibility of the substrate in the enzymes' active sites. For lentzeadiene an intriguing thermal [1,5]-sigmatropic rearrangement was discovered, reminiscent of the biosynthesis of vitamin D3. All enzyme reactions and the [1,5]-sigmatropic rearrangement were investigated through isotopic labeling experiments and DFT calculations. The results also emphasize the importance of conformational changes during terpene cyclizations.
Collapse
Affiliation(s)
- Binbin Gu
- Kekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk-Straße 1, 53121, Bonn, Germany
| | - Bernd Goldfuss
- Department for Chemistry, University of Cologne, Greinstraße 4, 50939, Cologne, Germany
| | - Jeroen S Dickschat
- Kekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk-Straße 1, 53121, Bonn, Germany
| |
Collapse
|
3
|
Yan D, Arakelyan J, Wan T, Raina R, Chan TK, Ahn D, Kushnarev V, Cheung TK, Chan HC, Choi I, Ho PY, Hu F, Kim Y, Lau HL, Law YL, Leung CS, Tong CY, Wong KK, Yim WL, Karnaukhov NS, Kong RY, Babak MV, Matsuda Y. Genomics-driven derivatization of the bioactive fungal sesterterpenoid variecolin: Creation of an unnatural analogue with improved anticancer properties. Acta Pharm Sin B 2024; 14:421-432. [PMID: 38261827 PMCID: PMC10793096 DOI: 10.1016/j.apsb.2023.08.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 07/25/2023] [Accepted: 08/24/2023] [Indexed: 01/25/2024] Open
Abstract
A biosynthetic gene cluster for the bioactive fungal sesterterpenoids variecolin (1) and variecolactone (2) was identified in Aspergillus aculeatus ATCC 16872. Heterologous production of 1 and 2 was achieved in Aspergillus oryzae by expressing the sesterterpene synthase VrcA and the cytochrome P450 VrcB. Intriguingly, the replacement of VrcB with homologous P450s from other fungal terpenoid pathways yielded three new variecolin analogues (5-7). Analysis of the compounds' anticancer activity in vitro and in vivo revealed that although 5 and 1 had comparable activities, 5 was associated with significantly reduced toxic side effects in cancer-bearing mice, indicating its potentially broader therapeutic window. Our study describes the first tests of variecolin and its analogues in animals and demonstrates the utility of synthetic biology for creating molecules with improved biological activities.
Collapse
Affiliation(s)
- Dexiu Yan
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Jemma Arakelyan
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Teng Wan
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Ritvik Raina
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
- Department of Biomedical Engineering, City University of Hong Kong, Hong Kong SAR, China
| | - Tsz Ki Chan
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Dohyun Ahn
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Vladimir Kushnarev
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
| | - Tsz Kiu Cheung
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Ho Ching Chan
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Inseo Choi
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Pui Yi Ho
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Feijun Hu
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Yujeong Kim
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Hill Lam Lau
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Ying Lo Law
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Chi Seng Leung
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Chun Yin Tong
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Kai Kap Wong
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Wing Lam Yim
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Nikolay S. Karnaukhov
- Moscow Clinical Research Center Named After A.S. Loginov, Moscow 111123, Russian Federation
| | - Richard Y.C. Kong
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Maria V. Babak
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| | - Yudai Matsuda
- Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China
- iGEM Team “VarieCure”, City University of Hong Kong, Hong Kong SAR, China
| |
Collapse
|